Skip to main content
SpringerLink
Log in

Refractoriness and Conduction Interaction During Modulation of Non-Ischemic Ventricular Fibrillation by Flecainide

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Purpose: To study refractoriness and conduction interaction during modulation of non-ischemic ventricular fibrillation (VF) by flecainide.

Methods: Isolated feline and rabbit hearts were used. (a) In the feline hearts (n = 8), electrophysiological parameters were measured before and after flecainide administration (0.6, 1.2 × 10−6 M). During pacing the parameters were: epicardial conduction time, refractoriness and 1:1 pacing/response capture. During 8 min of electrically-induced tachyarrhythmias they included heart rate and normalized entropy reflecting the degree of organization. (b) In rabbit hearts (n = 4), three-dimensional mapping was performed before and after flecainide administration (2 × 10−6 M). To follow changes in organization, local RR-intervals and differences in activation time between adjacent epicardial electrodes were measured immediately and 80 sec after VF induction.

Results: In feline hearts with flecainide, fibrillation was more difficult to induce, more frequently terminated spontaneously and was slower and more organized; conduction time was markedly lengthened, and refractoriness less than 1:1 capture, was moderately prolonged. An inverse correlation was observed between arrhythmia properties, rate and organization, and changes in refractoriness and conduction time. In rabbit, the number of wave fronts was reduced, RR-intervals were prolonged but at the same time activation time differences between adjacent electrodes were smaller following flecainide administration.

Conclusions: It is suggested that flecainide modulation of VF properties is associated with conduction suppression and refractoriness prolongation, which act in a synergistic, additive way.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lee J, Kamjoo K, Hough D, et al. Reentrant wave fronts in Wiggers' stage II ventricular fibrillation. Circ Res 1996;78:660-675.

    Google Scholar 

  2. Kwan YY, Fan W, Kamjoo K, et al. The effects of procainamide on the characteristics of functional reentry in canine ventricular fibrillation. Circulation 1998;97:1828-1836.

    Google Scholar 

  3. Pertsov AM, Davidenko JM, Salomonsz R, Baxter WT, Jalife J. Spiral waves of excitation underlies reentrant activity in isolated cardiac muscle. Circ Res 1993;72:631-650.

    Google Scholar 

  4. Moe GK, Rheinboldt WL, Abildskov JA. A computer model of atrial fibrillation. Am Heart J 1964;64:200-220.

    Google Scholar 

  5. Choi BR, Liu T, Salama G. The distribution of refractory periods influences the dynamics of ventricular fibrillation. Circ Res 2001;88:e49-e58.

    Google Scholar 

  6. Karma A. Spiral breakup in model equations of action potential propagation in cardiac tissue. Phys Rev Lett 1993;71:1103-1106.

    Google Scholar 

  7. Kim YH, Yashima M, Wu TJ, Doshi R, Chen PS, Karagueuzian HS. Mechanisms of procaine-induced prevention of spontaneous wave break during ventricular fibrillation. Insight into the maintenance of fibrillation wave fronts. Circulation 1999;100:666-674.

    Google Scholar 

  8. Mandapati R, Asano Y, Baxter WT, Gray R, Davidenko J, Jalife J. Quantification of effects of global ischemia on dynamics of ventricular fibrillation in isolated rabbit heart. Circulation 1998;98:1688-1696.

    Google Scholar 

  9. Amitzur G, Schoels W, Visokovsky A, et al. Role of sodium channels in ventricular fibrillation: A study in non-ischemic isolated hearts. J Cadiovasc Pharmacol 2000;36:785-793.

    Google Scholar 

  10. Zipes DP. Management of cardiac arrhythmias: Pharmacological, electrical and surgical technique. In: Braunwald E, ed. Heart Disease, 5th ed. Philadelphia: WB Saunders, 1997:593-639.

    Google Scholar 

  11. Martin DK, Nakaya Y, Wyse KR, Campbell TJ. Effects of disopyramide and flecainide on the kinetics of inward rectification potassium channels in rabbit heart muscle. Br J Pharmacol 1994;11:873-879.

    Google Scholar 

  12. Nemeth M, Virag L, Varro A, Papp JG. Comparison of the effects of restracorin and flecainide on various cardiac transmembrane potassium currents. Acta Physiol Hung 1996;84:317-328.

    Google Scholar 

  13. Eckardt L, HaverkampW, Gottker U, et al. Divergent effect of acute ventricular dilatation on the electrophysiologic characteristics of d,l-sotalol and flecainide in the isolated rabbit heart. J Cardiovasc Electrophysiol 1998;9:366-383.

    Google Scholar 

  14. Balderstob SM, Johnson KE, Reiter MJ. Electrophysiologic evaluation of cardiovascular agents in the isolated intact rabbit heart. J Pharmacol Meth 1991;25:205-213.

    Google Scholar 

  15. Kinnaird A, Lederman CL, Man RYK. Electrophysiological actions of flecainide in normal and infracted canine purkinje fibers. Eur J Pharmacol 1985;112:57-64.

    Google Scholar 

  16. Ikeda N, Singh BN, Davis LD, Hauswirth. Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers. J Am Coll Cardiol 1985;5:303-310.

    Google Scholar 

  17. Lang J, Timour Q, Aupett JF, Lancon JP, Lakhal M, Faucon G. Frequency and time-dependent depression of ventricular distal conduction by two novel antiarrhythmic drugs, cibenzoline and flecainide. Arch Int Pharmacodyn 1988;293:97-108.

    Google Scholar 

  18. Brugada J, Boersma L, Kirchof C, Allessie M. Proarrhythmic effects of flecainide. Experimental evidence for increased susceptibility to reentrant arrhythmias. Circulation 1991;84:1808-1818.

    Google Scholar 

  19. Follmer CH, Colatsky TJ. Block of delayed rectifier potassium current, Ik, by flecainide & E-4031 in cat ventricular myocytes. Circulation 1990;82:289-293.

    Google Scholar 

  20. Amitzur G, Pogatz V, Nobikov I, Kaplinsky E, Eldar M. Modulation of ventricular fibrillation in the isolated heart; the role of slow calcium channel activity under continuous perfusion. J Cardiovasc Pharmacol 2000;35:16-28.

    Google Scholar 

  21. Merillat J, Lakatta EG, Hano O, Guarnieri T. Role of calcium and the calcium channel in the initiation and maintenance of ventricular fibrillation. Circ Res 1990;67:1115-1123.

    Google Scholar 

  22. Oppenheim AV, Schafer RW. Digital Signal Processing. Prentice Hall Co., Inc., 1975.

  23. Kullback S. Information Theory and Statistics. New York: Dover Co., Inc., 1968.

    Google Scholar 

  24. Freigang KD, Bauer A, Becker R, et al. Differential effects of d-sotalol on normal and infarcted myocardium: An experimental study using epicardial mapping. Cardiovasc Res 1997;35:52-59.

    Google Scholar 

  25. Krishan SC, Antzelevich C. Sodium channel block produces opposite electrophysiological effects in canine ventricular epicardium and endocardium. Circ Res 1991;69:277-291.

    Google Scholar 

  26. Steinberg MI, Molloy BB. Clofilium-a new anti-fibrillatory agent that selectively increases cellular refractoriness. Life Sci 1979;25:1397-1406.

    Google Scholar 

  27. Allessie MA, Wijffels MC, Dorland R. Mechanisms of pharmacologic cardioversion of atrial fibrillation by class I drugs. J Cardiovasc Electrophysiol 1998;9(suppl):S69-S77.

    Google Scholar 

  28. Chorro FJ, Canoves J, Guerrero J, et al. Alteration of ventricular fibrillation by flecainide, verapamil, and sotalol. An experimental study. Circulation 2000;101:1606-1615.

    Google Scholar 

  29. Mueller M, Amitzur G, Bauer A, Kraft P, Schoels W. Electrical remodeling during ventricular fibrillation: Effects of class I antiarrhythmic drugs (abstr). Pace 1999;22:819.

    Google Scholar 

  30. The Cardiac Arrhythmias SuppressionTrials (CAST) Investigators: Effect of encainide and flecainide on mortality in randomized trial of arrhythmia suppression after mycardial infarction. N Engl J Med 1989;321:406-412.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neufeld Cardiac Research Institute, Tel Aviv University, Israel

    Giora Amitzur

  2. Neufeld Cardiac Research Institute, Tel Aviv University, Israel

    Nitza Shenkar, Ilia Novikov, Michael Eldar, Jonathan Leor & Eugenia Raichlin

  3. Department of Cardiology, University of Heidelberg, Germany

    Matthias Mueller, Patricia Kraft & Wolfgang Schoels

Authors
  1. Giora Amitzur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nitza Shenkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthias Mueller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patricia Kraft
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ilia Novikov
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michael Eldar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jonathan Leor
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Eugenia Raichlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Wolfgang Schoels
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amitzur, G., Shenkar, N., Mueller, M. et al. Refractoriness and Conduction Interaction During Modulation of Non-Ischemic Ventricular Fibrillation by Flecainide. Cardiovasc Drugs Ther 17, 237–247 (2003). https://doi.org/10.1023/A:1026124224369

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026124224369

Search

Navigation